New rosacea campaign launches

13 Nov 2019

A campaign aiming to empower and equip rosacea patients to discuss the true burden of their disease with a dermatologist called Face Up To Rosacea has launched.

Headed by global pharmaceutical company Galderma, the campaign provides a website that acts as a resource for rosacea support.

The website guides patients through a series of questions relating to their individual signs and symptoms, how their rosacea makes them feel and what treatments they have used in the past, before creating a personalised appointment guide for the user to take to their next consultation.

According to research by Galderma in 2018 comprising 710 patients across six countries, approximately 82% of patients surveyed felt their rosacea was not under control, and one in five people made substantial adjustments to their daily life because of their rosacea.

“Great consultations always start when patients come with a list of signs, symptoms and triggers which bother them and what treatments they’ve tried before that have or haven’t worked. With this information, we can really customise their treatment plans to help them break the cycle of rosacea,” said dermatologist Dr Melinda Gooderham, medical director at the SKiN Centre for Dermatology in Ontario, Canada.

Dr Kamel Chaouche, head of global medical affairs, prescription, Galderma, said, “Galderma is committed to advancing rosacea patient care. By listening to the views of rosacea sufferers and healthcare professionals (HCP) from around the world we identified an opportunity to support the patient-HCP dialogue in a really tangible way. The new patient appointment guide has the potential to truly revolutionise future rosacea appointments, leading to better outcomes.”


Log-in to post a comment

  • Mrs Tracey Wilson 13 Nov 2019 / 6:27 PM

    Demodex mites (when researched on google images) might be the way forward with rosacea. Most sufferers are unaware that these microscopic parasites are causing the problem. Perhaps the treatment of this horrible condition needs to be targeted towards finding out what stops them reproducing or kills them off without upsetting vital barrier functions. Perhaps if Patients saw the pictures, they would be a little more inclined to stick to treatment programmes they have been given.